You just read:

Mundipharma EDO GmbH Initiates Expansion Phase of First-in-human Trial to Investigate Use of Tinostamustine in Rare and Difficult-to-treat Blood Cancers

News provided by

Mundipharma EDO

05 Mar, 2019, 13:30 GMT